688622 (Hexin Instruments/SinoCellTech Engineering) Entry into Strong Stock Pool Analysis: Short-term Performance and Long-term Potential

688622 entered the strong stock pool today, attracting market attention. It should be noted that there is a

• Internal analysis [0] shows that 688622 is
  Hexin Instruments
  , a national-level specialized, sophisticated, unique, and new “little giant” enterprise focusing on environmental monitoring mass spectrometers;
• Another internal analysis [1] points out that 688622 corresponds to
  SinoCellTech Engineering
  , a biopharmaceutical company engaged in monoclonal antibodies and cell therapy.
  This discrepancy needs further verification to ensure the accuracy of investment decisions.

If it is Hexin Instruments:

• Core Business: R&D, production, and sales of environmental monitoring mass spectrometers, such as the SPAMS series online source apportionment mass spectrometer;
• Policy Advantages: Benefits from domestic scientific instrument substitution and environmental protection policies;
• 2025 Q1-Q3 Financials: Revenue of 70.54 million yuan (YoY -52.81%), net loss of 36.20 million yuan (YoY -63.40%), number of shareholders: 3228 (+27.54% YoY).

##3. Industry Background

• Environmental Monitoring ([0])
  : Stricter environmental protection policies drive demand, with large room for domestic instrument substitution;
• Biopharmaceuticals ([1])
  : A hot track in 2024-2025, benefiting from innovative drug policies, technological breakthroughs, and capital attention.

##4. Reasons for Strong Performance
Possible factors include: long-term policy logic (domestic substitution/innovative drugs), short-term capital inflow, and rising retail investor attention (increase in shareholder count).

##5. Risks and Outlook

• Financial Pressure: Short-term revenue decline and expanding losses;
• Information Uncertainty: Discrepancy in company identity;
• Industry Competition: Fierce competition in the environmental monitoring and biopharmaceutical sectors.

• If it is Hexin Instruments: Long-term benefits from environmental protection and domestic substitution policies;
• If it is SinoCellTech Engineering: Potential comes from biopharmaceutical innovation and globalization.

688622’s entry into the strong stock pool reflects market attention, but investors should first verify the company’s identity before evaluating based on long-term trends and short-term financials.